Disparities in postdischarge follow-up and risk of readmission between Medicaid and privately insured patients.
Journal
Journal of hospital medicine
ISSN: 1553-5606
Titre abrégé: J Hosp Med
Pays: United States
ID NLM: 101271025
Informations de publication
Date de publication:
20 Aug 2024
20 Aug 2024
Historique:
revised:
22
07
2024
received:
19
02
2024
accepted:
04
08
2024
medline:
21
8
2024
pubmed:
21
8
2024
entrez:
21
8
2024
Statut:
aheadofprint
Résumé
Studies have identified higher risk of readmission for patients with Medicaid compared to those with private insurance. Postdischarge follow-up is utilized as an intervention to reduce readmissions in the Medicare population, but it is unclear whether follow-up reduces risk of readmission for patients with Medicaid. To assess whether follow-up within 30 days of discharge reduces risk of readmission and mitigates readmission disparities based upon insurance status. This retrospective cohort study used Cox proportional hazard and competing risk models to estimate associations between sociodemographic and clinical characteristics, follow-up, and readmission. We analyzed data from 4281 patients aged 21-64 years with Medicaid or private insurance who were hospitalized from January 2017 to December 2019 for one of five conditions associated with high risk of readmission. Outpatient follow-up within 30 days of discharge and 30-day all-cause readmission were outcomes. Overall risk of readmission was similar for Medicaid and privately insured patients in this cohort (13.7% and 14.5%, respectively). Patients with Medicaid were 23% points less likely to complete outpatient follow-up within 30 days compared to patients with private insurance (p < .001). However, outpatient follow-up before readmission within 30 days of discharge was not associated with a significant difference in readmission rate (hazard ratio: 1.10, 95% confidence interval: 0.91-1.32) in the overall sample or in analysis stratified by payer. We found similar rates of readmission for Medicaid and privately insured patients despite significant disparities in postdischarge follow-up. Timely follow-up care alone may not be sufficient as an intervention to reduce readmissions.
Sections du résumé
BACKGROUND
BACKGROUND
Studies have identified higher risk of readmission for patients with Medicaid compared to those with private insurance. Postdischarge follow-up is utilized as an intervention to reduce readmissions in the Medicare population, but it is unclear whether follow-up reduces risk of readmission for patients with Medicaid.
OBJECTIVE
OBJECTIVE
To assess whether follow-up within 30 days of discharge reduces risk of readmission and mitigates readmission disparities based upon insurance status.
METHODS
METHODS
This retrospective cohort study used Cox proportional hazard and competing risk models to estimate associations between sociodemographic and clinical characteristics, follow-up, and readmission. We analyzed data from 4281 patients aged 21-64 years with Medicaid or private insurance who were hospitalized from January 2017 to December 2019 for one of five conditions associated with high risk of readmission. Outpatient follow-up within 30 days of discharge and 30-day all-cause readmission were outcomes.
RESULTS
RESULTS
Overall risk of readmission was similar for Medicaid and privately insured patients in this cohort (13.7% and 14.5%, respectively). Patients with Medicaid were 23% points less likely to complete outpatient follow-up within 30 days compared to patients with private insurance (p < .001). However, outpatient follow-up before readmission within 30 days of discharge was not associated with a significant difference in readmission rate (hazard ratio: 1.10, 95% confidence interval: 0.91-1.32) in the overall sample or in analysis stratified by payer.
CONCLUSIONS
CONCLUSIONS
We found similar rates of readmission for Medicaid and privately insured patients despite significant disparities in postdischarge follow-up. Timely follow-up care alone may not be sufficient as an intervention to reduce readmissions.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR002535
Pays : United States
Informations de copyright
© 2024 Society of Hospital Medicine.
Références
Sommers A, Cunningham PJ. Physician visits after hospital discharge: implications for reducing readmissions. Natl Inst Health Care Reform. 2011;6:1‐9.
Auerbach AD, Kripalani S, Vasilevskis EE, et al. Preventability and causes of readmissions in a national cohort of general medicine patients. JAMA Int Med. 2016;176(4):484‐493.
(MedPAC) MPAC. Promoting Greater Efficiency in Medicare. Promoting Greater Efficiency in Medicare. Report to Congress (MedPAC) MPAC; 2007.
Goldfield NI, McCullough EC, Hughes JS, et al. Identifying potentially preventable readmissions. Health Care Financ Rev. 2008;30(1):75‐91.
Barrett ML, Wier LM, Jiang HJ, Steiner CA. All‐Cause Readmissions by Payer and Age, 2009–2013. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs; 2006.
Coffey RM, Misra A, Barrett M, Andrews RM, Mutter R, Moy E. Congestive heart failure: who is likely to be readmitted? Med Care Res Rev. 2012;69(5):602‐616.
Podulka J, Barrett M, Jiang HJ, Steiner C. 30‐day Readmissions Following Hospitalizations for Chronic vs Acute Conditions. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs.; 2012.
Regenstein M, Andres E. Reducing hospital readmissions among medicaid patients: a review of the literature. Qual Manag Healthcare. 2014;23(4):203‐225.
Jackson C, Shahsahebi M, Wedlake T, DuBard CA. Timeliness of outpatient follow‐up: an evidence‐based approach for planning after hospital discharge. Ann Family Med. 2015;13(2):115‐122.
Wiest D, Yang Q, Wilson C, Dravid N. Outcomes of a citywide campaign to reduce Medicaid hospital readmissions with connection to primary care within 7 days of hospital discharge. JAMA Netw Open. 2019;2(1):e187369.
Anderson A, Mills CW, Willits J, et al. Follow‐up post‐discharge and readmission disparities among medicare fee‐for‐service beneficiaries, 2018. J Gen Intern Med. 2022;37(12):3020‐3028.
O'Neil SS, Lake T, Merrill A, Wilson A, Mann DA, Bartnyska LM. Racial disparities in hospitalizations for ambulatory care‐sensitive conditions. Am J Prev Med. 2010;38(4):381‐388.
MACStats: Medicaid and CHIP Data Book; 2020. https://www.macpac.gov/wp-content/uploads/2020/12/MACStats-Medicaidand-CHIP-Data-Book-December-2020.pdf
Colorado Hospital Transformation Program; 2023. https://hcpf.colorado.gov/colorado-hospital-transformation-program
Bruen BJR, Riley P, Lara A, Lu X. Medicaid Cost Containment Options for Washington State; 2011. George Washington University Report for the Washington State Legislature and the Washington State Institute for Public Policy.
DiNapoli TP. Medicaid Overpayments for Hospital Readmissions. 2010.
Texas Health and Human Services Commission. Potentially Preventable Readmissions in the Texas Medicaid Population, State Fiscal Year 2011. Texas Health and Human Services Commission. 2012.
Banerjee S, Paasche‐Orlow MK, McCormick D, Lin M‐Y, Hanchate AD. Readmissions performance and penalty experience of safety‐net hospitals under Medicare's Hospital Readmissions Reduction Program. BMC Health Serv Res. 2022;22(1):338.
Healthcare Cost and Utilization Project (HCUP). Clinical Classifications Software Refined (CCSR) for ICD‐10‐CM Diagnoses. Healthcare Cost and Utilization Project (HCUP).2024. Accessed August 14, 2024. https://hcup-us.ahrq.gov/toolssoftware/ccsr/ccs_refined.jsp
Tipirneni R, Karmakar M, O'Malley M, Prescott HC, Chopra V. Contribution of individual‐and neighborhood‐level social, demographic, and health factors to COVID‐19 hospitalization outcomes. Ann Intern Med. 2022;175(4):505‐512.
Norton EC, Dowd BE, Maciejewski ML. Marginal effects—quantifying the effect of changes in risk factors in logistic regression models. JAMA. 2019;321(13):1304‐1305.
Allen LA, Tomic KES, Smith DM, Wilson KL, Agodoa I. Rates and predictors of 30‐day readmission among commercially insured and Medicaid‐enrolled patients hospitalized with systolic heart failure. Circ Heart Fail. 2012;5(6):672‐679.
Ferro EG, Secemsky EA, Wadhera RK, et al. Patient readmission rates for all insurance types after implementation of the hospital readmissions reduction program. Health Aff. 2019;38(4):585‐593.
Jiang HJ, Hensche M. Characteristics of 30‐Day All‐Cause Hospital Readmissions, 2016‐2020. Agency for Healthcare Research and Quality. September 2023. Accessed July 18, 2024. https://hcup-us.ahrq.gov/reports/statbriefs/sb304-readmissions-2016-2020.jsp
Austin AE, Naumann RB, Short NA. Association between medicaid expansion and suicide mortality among nonelderly US adults. Am J Epidemiol. 2021;190(9):1760‐1769. doi:10.1093/aje/kwab130
Khodneva Y, Levitan EB, Arora P, Presley CA, Oparil S, Cherrington AL. Disparities in postdischarge ambulatory care follow‐up among medicaid beneficiaries with diabetes, hospitalized for heart failure. J Am Heart Assoc. 2023;12(12):e029094.
Accountable Care Collaborative. Colorado Department of Health Care Policy & Financing. Accessed August 27, 2023. https://hcpf.colorado.gov/accphase2
Meyer ML, Atherly A. Effect of a Medicaid accountable care collaborative on 30‐day hospital readmission rates. Popul Health Manag. 2021;24(2):190‐197.
Misky GJ, Burke RE, Johnson T, del Pino Jones A, Hanson JL, Reid MB. Hospital readmission from the perspective of Medicaid and uninsured patients. J Healthc Qual. 2018;40(1):44‐50.
Jackson CT, Trygstad TK, DeWalt DA, DuBard CA. Transitional care cut hospital readmissions for North Carolina Medicaid patients with complex chronic conditions. Health Aff. 2013;32(8):1407‐1415.
Coleman EA, Parry C, Chalmers S, Min S. The care transitions intervention: results of a randomized controlled trial. Arch Intern Med. 2006;166(17):1822‐1828.
Kaiser Family Foundation. Share of Medicaid Population Covered under Different Delivery Systems. Kaiser Family Foundation. 2022. Accessed April 25, 2024. https://www.kff.org/medicaid/state-indicator/share-of-medicaid-population-covered-under-different-delivery-systems/